Su TP - Search Results

1

Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.

Litman RE, Hong WW, Weissman EM, Su TP, Potter WZ, Pickar D. Litman RE, et al. Among authors: su tp. J Clin Psychopharmacol. 1993 Aug;13(4):264-7. J Clin Psychopharmacol. 1993. PMID: 8104200 Clinical Trial.

2

Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.

Litman RE, Su TP, Potter WZ, Hong WW, Pickar D. Litman RE, et al. Among authors: su tp. Br J Psychiatry. 1996 May;168(5):571-9. doi: 10.1192/bjp.168.5.571. Br J Psychiatry. 1996. PMID: 8733795 Clinical Trial.

3

Predictors of clozapine response in schizophrenia.

Pickar D, Owen RR Jr, Litman RE, Hsiao JK, Su TP. Pickar D, et al. Among authors: su tp. J Clin Psychiatry. 1994 Sep;55 Suppl B:129-32. J Clin Psychiatry. 1994. PMID: 7525541 Clinical Trial.

4

Clinical response to clozapine in patients with schizophrenia.

Pickar D, Litman RE, Hong WW, Su TP, Weissman EM, Hsiao JK, Potter WZ. Pickar D, et al. Among authors: su tp. Arch Gen Psychiatry. 1994 Feb;51(2):159-60. doi: 10.1001/archpsyc.1994.03950020083008. Arch Gen Psychiatry. 1994. PMID: 8297214 Clinical Trial. No abstract available.

5

Neuropsychiatric effects of anabolic steroids in male normal volunteers.

Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Su TP, et al. JAMA. 1993 Jun 2;269(21):2760-4. JAMA. 1993. PMID: 8492402 Clinical Trial.

6

Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.

Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D. Breier AF, et al. Among authors: su tp. Am J Psychiatry. 1999 Feb;156(2):294-8. doi: 10.1176/ajp.156.2.294. Am J Psychiatry. 1999. PMID: 9989566 Clinical Trial.

7

Spectrum of EEG abnormalities during clozapine treatment.

Malow BA, Reese KB, Sato S, Bogard PJ, Malhotra AK, Su TP, Pickar D. Malow BA, et al. Among authors: su tp. Electroencephalogr Clin Neurophysiol. 1994 Sep;91(3):205-11. doi: 10.1016/0013-4694(94)90070-1. Electroencephalogr Clin Neurophysiol. 1994. PMID: 7522149

8

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D. Breier A, et al. Among authors: su tp. Synapse. 1998 Jun;29(2):142-7. doi: 10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7. Synapse. 1998. PMID: 9593104 Clinical Trial.

9

Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers.

Daly RC, Su TP, Schmidt PJ, Pagliaro M, Pickar D, Rubinow DR. Daly RC, et al. Among authors: su tp. Psychoneuroendocrinology. 2003 Apr;28(3):317-31. doi: 10.1016/s0306-4530(02)00025-2. Psychoneuroendocrinology. 2003. PMID: 12573299 Clinical Trial.

10

Effects of atypical antipsychotic drug treatment on amphetamine-induced striatal dopamine release in patients with psychotic disorders.

Breier A, Su TP, Malhotra AK, Elman I, Adler CM, Weisenfeld NI, Pickar D. Breier A, et al. Among authors: su tp. Neuropsychopharmacology. 1999 Apr;20(4):340-5. doi: 10.1016/S0893-133X(98)00126-2. Neuropsychopharmacology. 1999. PMID: 10088134 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters